Nanobiotix SA
NBTX
Detailliertes Diagramm anzeigen
20.850USD
-0.180-0.86%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
1.01BMarktkapitalisierung
VerlustKGV TTM
Intraday
1m
30m
1h
D
W
M
D
Heute
-0.86%
5 Tage
-0.71%
1 Monat
+2.36%
6 Monate
+202.17%
Seit Jahresbeginn
-9.82%
1 Jahr
+492.33%
Detailliertes Diagramm anzeigen
TradingKey Aktien-Score
Kein Aktien-Score verfügbar aufgrund unzureichender Daten.
Nanobiotix SA Nachrichten
Bald gibt es mehr Neuigkeiten, bleiben Sie dran...
Finanzindikatoren
EPS
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Gesamteinnahmen
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nanobiotix SA Informationen
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
BörsenkürzelNBTX
UnternehmenNanobiotix SA
CEOLevy (Laurent)
Websitehttps://www.nanobiotix.com
Verwandte Finanzinstrumente
+3.66%
+3.17%
+0.93%
+1.99%
+1.78%
+1.60%
-0.95%
+4.49%
+2.10%
+10.00%
+2.72%
+4.15%
+1.81%
+4.17%
+0.72%
+1.06%
+2.46%
0.00%
+0.53%
+0.56%Beliebte Symbole
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68951.580
-1018.550 (-1.46%)
282.580
+22.390 (+8.61%)
2033.950
-17.780 (-0.87%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
